{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T11:56:42Z","timestamp":1791115002530,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T00:00:00Z","timestamp":1576195200000},"content-version":"vor","delay-in-days":2447,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100005972","name":"Deutsche Krebshilfe","doi-asserted-by":"publisher","award":["BMBF-FKZ 0315452"],"award-info":[{"award-number":["BMBF-FKZ 0315452"]}],"id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000651","name":"Leukaemia and Lymphoma Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000651","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001655","name":"Deutscher Akademischer Austauschdienst","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001655","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["GRK1034"],"award-info":[{"award-number":["GRK1034"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["FOR942"],"award-info":[{"award-number":["FOR942"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajp.amjpathol.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.ajpath.2012.12.013","type":"journal-article","created":{"date-parts":[[2013,1,31]],"date-time":"2013-01-31T02:16:56Z","timestamp":1359598616000},"page":"1092-1098","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Aberrant Lymphocyte Enhancer\u2013Binding Factor 1 Expression Is Characteristic for Sporadic Burkitt\u2019s Lymphoma"],"prefix":"10.1016","volume":"182","author":[{"given":"Neele","family":"Walther","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antje","family":"Ulrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Vockerodt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederike","family":"von Bonin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfram","family":"Klapper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja","family":"Eberth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Pukrop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"Spang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenz","family":"Tr\u00fcmper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter","family":"Kube","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpath.2012.12.013_bib1","series-title":"WHO classification of tumours of\u00a0haematopoietic and lymphoid tissues. Atlas of Hematologic Neoplasms","author":"Swerdlow","year":"2008"},{"key":"10.1016\/j.ajpath.2012.12.013_bib2","doi-asserted-by":"crossref","first-page":"5580","DOI":"10.1038\/sj.onc.1204640","article-title":"Mechanisms of chromosomal translocations in B cell lymphomas","volume":"20","author":"Kuppers","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.ajpath.2012.12.013_bib3","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1056\/NEJMoa055351","article-title":"A biologic definition of Burkitt\u2019s lymphoma from transcriptional and genomic profiling","volume":"354","author":"Hummel","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpath.2012.12.013_bib4","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.semcancer.2009.11.002","article-title":"Burkitt lymphoma","volume":"19","author":"Klein","year":"2009","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.ajpath.2012.12.013_bib5","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1101\/gad.5.5.880","article-title":"LEF-1, a gene encoding a lymphoid-specific protein with an HMG domain, regulates T-cell receptor alpha enhancer function","volume":"5","author":"Travis","year":"1991","journal-title":"Genes Dev"},{"key":"10.1016\/j.ajpath.2012.12.013_bib6","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1101\/gad.5.4.656","article-title":"A thymus-specific member of the HMG protein family regulates the human T cell receptor C alpha enhancer","volume":"5","author":"Waterman","year":"1991","journal-title":"Genes Dev"},{"key":"10.1016\/j.ajpath.2012.12.013_bib7","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/nri1529","article-title":"WNT signalling and haematopoiesis: a WNT-WNT situation","volume":"5","author":"Staal","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.ajpath.2012.12.013_bib8","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nri2360","article-title":"WNT signalling in the immune system: wNT is spreading its wings","volume":"8","author":"Staal","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.ajpath.2012.12.013_bib9","doi-asserted-by":"crossref","first-page":"6122","DOI":"10.1073\/pnas.0305855101","article-title":"Illegitimate WNT signaling promotes proliferation of multiple myeloma cells","volume":"101","author":"Derksen","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2012.12.013_bib10","doi-asserted-by":"crossref","first-page":"5171","DOI":"10.1182\/blood-2008-02-139212","article-title":"Constitutive activation of the Wnt canonical pathway in mantle cell lymphoma","volume":"112","author":"Gelebart","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.ajpath.2012.12.013_bib11","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.1158\/0008-5472.CAN-08-1322","article-title":"Illegitimate WNT pathway activation by beta-catenin mutation or autocrine stimulation in T-cell malignancies","volume":"68","author":"Groen","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2012.12.013_bib12","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/sj.leu.2404520","article-title":"Gene expression profiling of B lymphocytes and plasma cells from Waldenstrom\u2019s macroglobulinemia: comparison with expression patterns of the same cell counterparts from chronic lymphocytic leukemia, multiple myeloma and normal individuals","volume":"21","author":"Gutierrez","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.ajpath.2012.12.013_bib13","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S1535-6108(03)00268-X","article-title":"Wnt5a inhibits B cell proliferation and functions as a tumor suppressor in hematopoietic tissue","volume":"4","author":"Liang","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ajpath.2012.12.013_bib14","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.1073\/pnas.0308648100","article-title":"Activation of the Wnt signaling pathway in chronic lymphocytic leukemia","volume":"101","author":"Lu","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2012.12.013_bib15","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/nature05690","article-title":"Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia","volume":"446","author":"Mullighan","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.ajpath.2012.12.013_bib16","doi-asserted-by":"crossref","first-page":"3462","DOI":"10.1182\/blood-2006-09-047043","article-title":"Epigenetic regulation of Wnt-signaling pathway in acute lymphoblastic leukemia","volume":"109","author":"Roman-Gomez","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.ajpath.2012.12.013_bib17","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1038\/leu.2009.86","article-title":"Wnt signaling pathway is epigenetically regulated by methylation of Wnt antagonists in acute myeloid leukemia","volume":"23","author":"Valencia","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.ajpath.2012.12.013_bib18","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1182\/blood-2010-02-269878","article-title":"LEF-1 is a prosurvival factor in chronic lymphocytic leukemia and is expressed in the preleukemic state of monoclonal B cell lymphocytosis","volume":"116","author":"Gutierrez","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.ajpath.2012.12.013_bib19","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1182\/blood.V98.3.762","article-title":"STAT3 is constitutively activated in Hodgkin cell lines","volume":"98","author":"Kube","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.ajpath.2012.12.013_bib20","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1006\/viro.2000.0768","article-title":"The Epstein-Barr virus latent membrane protein 1 induces interleukin-10 in Burkitt\u2019s lymphoma cells but not in Hodgkin\u2019s cells involving the p38\/SAPK2 pathway","volume":"280","author":"Vockerodt","year":"2001","journal-title":"Virology"},{"key":"10.1016\/j.ajpath.2012.12.013_bib21","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/ijc.20759","article-title":"The Epstein-Barr virus oncoprotein latent membrane protein 1 induces expression of the chemokine IP-10: importance of mRNA half-life regulation","volume":"114","author":"Vockerodt","year":"2005","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ajpath.2012.12.013_bib22","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1038\/sj.leu.2403750","article-title":"STAT3 is essential for Hodgkin lymphoma cell proliferation and is a target of tyrphostin AG17 which confers sensitization for apoptosis","volume":"19","author":"Holtick","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.ajpath.2012.12.013_bib23","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1093\/bioinformatics\/bti270","article-title":"Use of within-array replicate spots for assessing differential expression in microarray experiments","volume":"21","author":"Smyth","year":"2005","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ajpath.2012.12.013_bib24","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Statist Soc B"},{"key":"10.1016\/j.ajpath.2012.12.013_bib25","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2012.12.013_bib26","doi-asserted-by":"crossref","first-page":"9309","DOI":"10.1073\/pnas.0401994101","article-title":"Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression","volume":"101","author":"Rhodes","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2012.12.013_bib27","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1073\/pnas.0437996100","article-title":"Transcriptional analysis of the B cell germinal center reaction","volume":"100","author":"Klein","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2012.12.013_bib28","doi-asserted-by":"crossref","first-page":"E348","DOI":"10.1002\/ijc.26423","article-title":"High Myc activity is an independent negative prognostic factor for diffuse large B cell lymphomas","volume":"131","author":"Schrader","year":"2012","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ajpath.2012.12.013_bib29","doi-asserted-by":"crossref","first-page":"5478","DOI":"10.1182\/blood-2012-01-403154","article-title":"Identification of LMO2 transcriptome and interactome in diffuse large B-cell lymphoma","volume":"119","author":"Cubedo","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.ajpath.2012.12.013_bib30","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1593\/neo.91972","article-title":"Small molecule inhibitors of Wnt\/beta-catenin\/lef-1 signaling induces apoptosis in chronic lymphocytic leukemia cells in\u00a0vitro and in\u00a0vivo","volume":"12","author":"Gandhirajan","year":"2010","journal-title":"Neoplasia"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944013000229?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944013000229?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T11:03:27Z","timestamp":1762081407000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944013000229"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0002944013000229"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2012.12.013","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aberrant Lymphocyte Enhancer\u2013Binding Factor 1 Expression Is Characteristic for Sporadic Burkitt\u2019s Lymphoma","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpath.2012.12.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}